 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Oramon, Somnifane, Allonal |
| Other names | aprobarbitone, allylpropymal, Alurate, 5-isopropyl- 5-allylbarbituric acid |
| AHFS/Drugs.com | International Drug Names |
| Drug class | Barbiturate |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.908 |
| Chemical and physical data | |
| Formula | C10H14N2O3 |
| Molar mass | 210.233 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Aprobarbital (oraprobarbitone), sold under the brand namesOramon,Somnifaine, andAllonal, is abarbiturate derivative invented in the 1920s by Ernst Preiswerk. It hassedative,hypnotic, andanticonvulsant properties, and was used primarily for the treatment ofinsomnia.[2] Aprobarbital was never as widely used as more common barbiturate derivatives such asphenobarbital and is now rarely prescribed. It has been largely replaced by newer drugs with a better safety margin.
